CVS Health Corporation (NYSE:CVS) Shares Bought by Atlas Capital Advisors Inc.

Key Points

• Atlas Capital Advisors Inc. significantly increased its stake in CVS Health Corporation by 1,463.2% during Q1, acquiring an additional 15,817 shares, raising their total to 16,898 shares valued at approximately $1.145 million.
• Several institutional investors, including Vanguard Group and Dodge & Cox, have also increased their holdings in CVS Health, reflecting a strong interest in the company's stock among hedge funds.
• CVS Health recently reported a quarterly profit of $1.81 per share, exceeding analysts' expectations, with total revenue of $98.92 billion, up 8.4% year-over-year.

Atlas Capital Advisors Inc. boosted its position in CVS Health Corporation (NYSE:CVS - Free Report) by 1,463.2% during the 1st quarter, according to its most recent Form 13F filing with the SEC. The fund owned 16,898 shares of the pharmacy operator's stock after purchasing an additional 15,817 shares during the period. Atlas Capital Advisors Inc.'s holdings in CVS Health were worth $1,145,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also bought and sold shares of CVS. McIlrath & Eck LLC boosted its position in CVS Health by 32.6% in the fourth quarter. McIlrath & Eck LLC now owns 707 shares of the pharmacy operator's stock worth $32,000 after purchasing an additional 174 shares during the last quarter. Costello Asset Management INC boosted its position in CVS Health by 281.3% in the first quarter. Costello Asset Management INC now owns 572 shares of the pharmacy operator's stock worth $39,000 after purchasing an additional 422 shares during the last quarter. Park Square Financial Group LLC purchased a new position in CVS Health in the fourth quarter worth about $43,000. GW&K Investment Management LLC raised its stake in shares of CVS Health by 39.4% in the first quarter. GW&K Investment Management LLC now owns 637 shares of the pharmacy operator's stock worth $43,000 after buying an additional 180 shares during the period. Finally, Strategic Investment Solutions Inc. IL raised its stake in shares of CVS Health by 77.2% in the fourth quarter. Strategic Investment Solutions Inc. IL now owns 1,024 shares of the pharmacy operator's stock worth $46,000 after buying an additional 446 shares during the period. 80.66% of the stock is owned by hedge funds and other institutional investors.

CVS Health Stock Down 1.0%

NYSE:CVS traded down $0.64 during mid-day trading on Monday, hitting $64.91. 5,554,636 shares of the company's stock traded hands, compared to its average volume of 9,220,690. The company has a fifty day moving average of $64.71 and a 200 day moving average of $64.45. CVS Health Corporation has a twelve month low of $43.56 and a twelve month high of $72.51. The company has a market capitalization of $82.32 billion, a P/E ratio of 18.13, a P/E/G ratio of 0.72 and a beta of 0.58. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.62 and a current ratio of 0.80.

CVS Health (NYSE:CVS - Get Free Report) last posted its quarterly earnings results on Thursday, July 31st. The pharmacy operator reported $1.81 earnings per share for the quarter, beating the consensus estimate of $1.46 by $0.35. The business had revenue of $98.92 billion for the quarter, compared to the consensus estimate of $94.87 billion. CVS Health had a return on equity of 10.51% and a net margin of 1.17%. The company's quarterly revenue was up 8.4% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.83 EPS. On average, analysts forecast that CVS Health Corporation will post 5.89 EPS for the current year.

CVS Health Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, August 1st. Shareholders of record on Tuesday, July 22nd were given a dividend of $0.665 per share. The ex-dividend date was Tuesday, July 22nd. This represents a $2.66 dividend on an annualized basis and a yield of 4.1%. CVS Health's dividend payout ratio is currently 74.30%.

Wall Street Analyst Weigh In

Several research analysts have recently commented on the company. UBS Group decreased their price objective on CVS Health from $71.00 to $67.00 and set a "neutral" rating on the stock in a research note on Tuesday, July 22nd. Jefferies Financial Group lifted their target price on CVS Health from $74.00 to $80.00 and gave the company a "buy" rating in a research note on Monday, June 30th. Truist Financial lifted their target price on CVS Health from $82.00 to $84.00 and gave the company a "buy" rating in a research note on Monday, May 12th. Wells Fargo & Company reissued an "overweight" rating and set a $84.00 target price (up previously from $76.00) on shares of CVS Health in a research note on Tuesday, May 6th. Finally, Royal Bank Of Canada lifted their target price on CVS Health from $74.00 to $81.00 and gave the company an "outperform" rating in a research note on Monday, May 5th. Three analysts have rated the stock with a hold rating, eighteen have given a buy rating and one has issued a strong buy rating to the company's stock. According to MarketBeat, CVS Health presently has an average rating of "Moderate Buy" and an average price target of $75.11.

Insider Transactions at CVS Health

In other news, Director Guy P. Sansone bought 1,570 shares of the firm's stock in a transaction dated Thursday, June 5th. The shares were acquired at an average price of $63.70 per share, for a total transaction of $100,009.00. Following the completion of the transaction, the director directly owned 12,007 shares in the company, valued at $764,845.90. The trade was a 15.04% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Corporate insiders own 1.22% of the company's stock.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.